Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (HLTC) Cash from Financing Activities (2016 - 2025)

National Healthcare Properties (HLTC) has 13 years of Cash from Financing Activities data on record, last reported at -$712000.0 in Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 96.86% year-over-year to -$712000.0; the TTM value through Dec 2025 reached -$42.4 million, down 3047.74%, while the annual FY2025 figure was -$42.4 million, 3047.74% down from the prior year.
  • Cash from Financing Activities reached -$712000.0 in Q4 2025 per HLTC's latest filing, up from -$7.8 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $82.5 million in Q3 2021 and bottomed at -$78.5 million in Q2 2021.
  • Average Cash from Financing Activities over 5 years is $1.0 million, with a median of -$2.9 million recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 1670.32% in 2022, then tumbled 2022.24% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $1.4 million in 2021, then surged by 1670.32% to $24.4 million in 2022, then tumbled by 64.97% to $8.5 million in 2023, then plummeted by 365.42% to -$22.7 million in 2024, then surged by 96.86% to -$712000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$712000.0 in Q4 2025, -$7.8 million in Q3 2025, and -$29.4 million in Q2 2025.